Pioneering Lasting Solutions for Lymphedema

COMING SOON:

Steer Biotherapeutics is a patient-driven company dedicated to eliminating the lifelong burden of lymphedema by harnessing breakthroughs in cell engineering, biomaterials, and regenerative medicine to develop transformative therapies that target the root causes of this chronic disease.

To restore lymphatic health, relieve patients from a lifetime of compression and surgical interventions, and deliver lasting solutions that change the standard of care.

Our mission:

With a team of pioneering scientists, clinicians, and advisors, SteerBio is building a future where lymphedema no longer limits lives.